Pages that link to "Q115642191"

The following pages link to Heidi Barth (Q115642191):

Displaying 39 items.

• Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I (Q24676039) (← links)
• Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. (Q27469468) (← links)
• Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines (Q27472837) (← links)
• Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection (Q27473382) (← links)
• Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction (Q27477606) (← links)
• CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection (Q27480351) (← links)
• Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells (Q27485559) (← links)
• Mouse models for the study of HCV infection and virus–host interactions (Q27486807) (← links)
• Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation (Q27486836) (← links)
• In Vitro and In Vivo Models for the Study of Human Polyomavirus Infection (Q28074684) (← links)
• Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents (Q28538891) (← links)
• Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. (Q30767073) (← links)
• Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy (Q34016463) (← links)
• Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles (Q34234246) (← links)
• Development of hepatitis C virus vaccines: challenges and progress. (Q34254941) (← links)
• A look behind closed doors: interaction of persistent viruses with dendritic cells (Q34335916) (← links)
• Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees (Q35249069) (← links)
• Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade (Q35501190) (← links)
• Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection (Q36005818) (← links)
• Neutralizing antibodies in hepatitis C virus infection (Q36179699) (← links)
• Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement. (Q36297604) (← links)
• Hepatitis C virus entry: molecular biology and clinical implications (Q36581588) (← links)
• Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy (Q36644831) (← links)
• Challenges for HCV vaccine development in HIV-HCV coinfection (Q38036684) (← links)
• Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy (Q38061723) (← links)
• Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate (Q38352468) (← links)
• Performance of the Liaison® XL Murex recHTLV-I/II Immunoassay in the Detection of HTLV-1/2 Antibodies in Serum (Q38719482) (← links)
• 45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches (Q38801394) (← links)
• Long-term storage and safe retrieval of human papillomavirus DNA using FTA elute cards (Q38925727) (← links)
• Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. (Q40052203) (← links)
• Problem-based learning in laboratory medicine resident education: a satisfaction survey (Q40257992) (← links)
• Toward standardization of BK virus monitoring: evaluation of the BK virus R-gene kit for quantification of BK viral load in urine, whole-blood, and plasma specimens. (Q41710377) (← links)
• Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells (Q41821195) (← links)
• Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion. (Q42980990) (← links)
• Uptake and presentation of hepatitis C virus-like particles by human dendritic cells (Q42990053) (← links)
• Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection (Q44357855) (← links)
• Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy. (Q45326184) (← links)
• Insights into the role of interferon lambda in hepatitis C virus infection (Q45370634) (← links)
• Comparison of six commercial tick-borne encephalitis IgM and IgG ELISA kits and the molecular characterization of their antigenic design (Q47549246) (← links)